Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
12.11
-0.22 (-1.78%)
At close: Aug 19, 2025, 11:11 AM

Dyne Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
435.45M 121.63M 172.15M 200.82M
Short-Term Investments
206.82M 1.47M 83.86M 175.75M
Long-Term Investments
n/a n/a 2.32M 2.31M
Other Long-Term Assets
1.94M 2.31M 9.58M n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
17.01M 6.28M 9.58M 5.82M
Total Current Assets
659.28M 129.38M 256.01M 382.39M
Property-Plant & Equipment
30.01M 33.39M 38.41M 40.96M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
31.95M 35.71M 50.31M 43.27M
Total Assets
691.23M 165.08M 306.32M 425.66M
Account Payables
6.56M 22.94M 5.26M 4.03M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
4.85M n/a 4.61M 3.89M
Other Current Liabilities
30.85M 12.94M 7.67M 11.81M
Total Current Liabilities
42.26M 51.09M 28.09M 28.72M
Long-Term Debt
n/a n/a 25.87M 28.74M
Other Long-Term Liabilities
n/a n/a -25.87M -28.74M
Total Long-Term Liabilities
19.14M 22.7M 25.87M 28.74M
Total Liabilities
61.4M 73.79M 53.96M 57.47M
Total Debt
23.99M 27.41M 30.48M 32.64M
Common Stock
10K 6K 6K 6K
Retained Earnings
-949.93M -632.51M -396.57M -228.47M
Comprehensive Income
6K n/a -571K -269K
Shareholders Equity
629.84M 91.29M 252.36M 368.2M
Total Investments
206.82M 1.47M 83.86M 175.75M